
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is a promising provider of consumer health care, beauty, and lifestyle products with strong growth potential evidenced by their expanding product lines, partnerships, and international presence. Additionally, the company's current valuation is attractive and they have a strong track record of financial success. However, the company may need to seek additional funding for future investments and acquisitions. Overall, analysts maintain a BUY rating for the stock and anticipate continued growth for Synergy CHC in the future.
Bears say
Synergy CHC is facing several fundamental challenges. The company has struggled with supply chain issues and out-of-stock items for key online products, which have negatively impacted sales. Additionally, their recent earnings reports were well below expectations and reflected weak performance in both revenue and profits due to the terminated ME distribution deal and decreased sales and margins. The competitive landscape is also intense, with Synergy facing strong competition from a wide range of other nutritional supplement companies, which could lead to reduced margins and profitability. Furthermore, the company is highly dependent on a small number of retail customers and is vulnerable to changes in consumer trends and demands, economic uncertainties, and regulatory risks.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares